FlowCardia

FlowCardia, acquired by C. R. Bard in 2010, developed and marketed products for the treatment of chronic total occlusions (CTOs) of coronary and peripheral arteries. Utilizing a technology known as high-frequency mechanical recanalization, the company developed the CROSSER™ System to safely and quickly break up CTOs allowing subsequent stent placement or balloon angioplasty and avoiding the trauma of cardiac surgery.

FlowCardia

Sunnyvale, CA

12.04.2009
This New Technology Simply Saved My Legs

Read More

07.02.2009
Plaque Piercing Device Relieves Patients’ Clogged Arteries

Read More